uMed (Pharmaceuticals and Biotechnology) Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 35

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 9

uMed (Pharmaceuticals and Biotechnology) General Information

Description

Developer of a medical research technology platform designed to provide access to healthcare research and delivery. The company's platform automates the clinical study process, creating patient registries that meet regulatory compliance and combine electronic health data with data captured from each patient that can include genomic and biomarker samples, enabling healthcare providers to participate in multiple research programs simultaneously, without increasing overhead or burdens on clinical teams.

Contact Information

Website
www.umed.io
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 8 Warner Yard
  • London EC1R 5EY
  • England, United Kingdom
+44 020
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Vertical(s)
Corporate Office
  • 8 Warner Yard
  • London EC1R 5EY
  • England, United Kingdom
+44 020

uMed (Pharmaceuticals and Biotechnology) Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

uMed (Pharmaceuticals and Biotechnology) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
6. Later Stage VC (Series A) 05-Jul-2023 Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
4. Early Stage VC 30-Nov-2020 Completed Generating Revenue
3. Seed Round 13-Jun-2019 Completed Generating Revenue
2. Angel (individual) 04-Dec-2018 $199K $199K Completed Startup
1. Accelerator/Incubator Completed Startup
To view uMed (Pharmaceuticals and Biotechnology)’s complete valuation and funding history, request access »

uMed (Pharmaceuticals and Biotechnology) Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A2 Preferebce
A Preference
A Preference
Ordinary
Ordinary
Ordinary 52,528 $0.000127 $0.6 $0.6 1x $0.6 0.35%
Ordinary 203,804 $0.000127 $0.62 $0.62 1x $0.62 1.38%
To view uMed (Pharmaceuticals and Biotechnology)’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

uMed (Pharmaceuticals and Biotechnology) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a medical research technology platform designed to provide access to healthcare research and delivery. The
Other Pharmaceuticals and Biotechnology
London, United Kingdom
35 As of 2025

Waltham, MA
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

uMed (Pharmaceuticals and Biotechnology) Competitors (4)

One of uMed (Pharmaceuticals and Biotechnology)’s 4 competitors is ArisGlobal, a Formerly PE-Backed company based in Waltham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ArisGlobal Formerly PE-Backed Waltham, MA
Medidata Solutions Formerly VC-backed New York, NY
PicnicAI Venture Capital-Backed San Francisco, CA
OM1 Venture Capital-Backed Boston, MA
To view uMed (Pharmaceuticals and Biotechnology)’s complete competitors history, request access »

uMed (Pharmaceuticals and Biotechnology) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

uMed (Pharmaceuticals and Biotechnology) Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Healthtech Hub Accelerator/Incubator
PharmStars Accelerator/Incubator
11.2 Capital Venture Capital Minority
Albion Crown VCT Venture Capital Minority
AlbionVC Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

uMed (Pharmaceuticals and Biotechnology) Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Cohort Science London, United Kingdom 2021

uMed (Pharmaceuticals and Biotechnology) FAQs

  • When was uMed (Pharmaceuticals and Biotechnology) founded?

    uMed (Pharmaceuticals and Biotechnology) was founded in 2017.

  • Where is uMed (Pharmaceuticals and Biotechnology) headquartered?

    uMed (Pharmaceuticals and Biotechnology) is headquartered in London, United Kingdom.

  • What is the size of uMed (Pharmaceuticals and Biotechnology)?

    uMed (Pharmaceuticals and Biotechnology) has 35 total employees.

  • What industry is uMed (Pharmaceuticals and Biotechnology) in?

    uMed (Pharmaceuticals and Biotechnology)’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is uMed (Pharmaceuticals and Biotechnology) a private or public company?

    uMed (Pharmaceuticals and Biotechnology) is a Private company.

  • What is uMed (Pharmaceuticals and Biotechnology)’s current revenue?

    The current revenue for uMed (Pharmaceuticals and Biotechnology) is .

  • How much funding has uMed (Pharmaceuticals and Biotechnology) raised over time?

    uMed (Pharmaceuticals and Biotechnology) has raised $18.1M.

  • Who are uMed (Pharmaceuticals and Biotechnology)’s investors?

    Healthtech Hub, PharmStars, 11.2 Capital, Albion Crown VCT, and AlbionVC are 5 of 9 investors who have invested in uMed (Pharmaceuticals and Biotechnology).

  • Who are uMed (Pharmaceuticals and Biotechnology)’s competitors?

    ArisGlobal, Medidata Solutions, PicnicAI, and OM1 are competitors of uMed (Pharmaceuticals and Biotechnology).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process